Published in ASAIO J on January 27, 2005
Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med (2001) 18.91
Cardiotoxicity of the cancer therapeutic agent imatinib mesylate. Nat Med (2006) 9.07
Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med (2007) 7.15
Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson (2008) 5.65
Multicenter bridge to transplantation with the HeartMate assist device: evaluation from another perspective. A rebuttal. J Thorac Cardiovasc Surg (2003) 5.03
Sinus of Valsalva aneurysm or fistula: management and outcome. Ann Thorac Surg (1999) 4.78
MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J (2008) 4.42
Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson (2013) 3.87
Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J (2004) 3.70
Primary cardiac sarcomas. Ann Thorac Surg (1991) 3.61
Salvage of infected left ventricular assist device with antibiotic beads. Plast Reconstr Surg (2014) 3.28
Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation (2012) 3.24
Aortic stiffness is increased in hypertrophic cardiomyopathy with myocardial fibrosis: novel insights in vascular function from magnetic resonance imaging. J Am Coll Cardiol (2009) 3.19
Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure. Circulation (2003) 2.75
Metabolic gene expression in fetal and failing human heart. Circulation (2001) 2.59
Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. JACC Cardiovasc Imaging (2009) 2.41
Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation (2007) 2.34
Surgical treatment of cardiac tumors: a 25-year experience. Ann Thorac Surg (1990) 2.34
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol (2010) 2.23
Improved cardiac function with glucose-insulin-potassium after aortocoronary bypass grafting. Ann Thorac Surg (1989) 2.17
Initial clinical experience with the Jarvik 2000 implantable axial-flow left ventricular assist system. Circulation (2002) 2.15
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation (2010) 2.14
Newer concepts for imaging anomalous aortic origin of the coronary arteries in adults. Catheter Cardiovasc Interv (2007) 2.12
Device-supported myocardial revascularization: safe help for sick hearts. Ann Thorac Surg (1992) 2.06
Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation (1997) 2.00
Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging. J Am Soc Echocardiogr (2008) 1.99
Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. Congest Heart Fail (2005) 1.99
Complete resection of a right atrial intracavitary metastatic melanoma. Ann Thorac Surg (1996) 1.95
Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovasc Magn Reson (2013) 1.94
The percutaneous ventricular assist device in severe refractory cardiogenic shock. J Am Coll Cardiol (2010) 1.94
Interrupted aortic arch in an adult single-stage extra-anatomic repair. Tex Heart Inst J (2002) 1.74
A micro-ribonucleic acid signature associated with recovery from assist device support in 2 groups of patients with severe heart failure. J Am Coll Cardiol (2011) 1.71
Coronary artery bypass for unsuccessful percutaneous transluminal coronary angioplasty. J Thorac Cardiovasc Surg (1984) 1.71
Multidetector computed tomographic angiography in planning of reoperative cardiothoracic surgery. Ann Thorac Surg (2008) 1.69
Extension of donor criteria in cardiac transplantation: surgical risk versus supply-side economics. Ann Thorac Surg (1990) 1.69
First permanent implant of the Jarvik 2000 Heart. Lancet (2000) 1.68
Transmission of retroviruses by transfusion of screened blood in patients undergoing cardiac surgery. N Engl J Med (1989) 1.67
Normal values for renal length and volume as measured by magnetic resonance imaging. Clin J Am Soc Nephrol (2006) 1.67
Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure. J Card Fail (2005) 1.66
Continuous-flow total artificial heart supports long-term survival of a calf. Tex Heart Inst J (2009) 1.64
Bedside right ventricular assist device removal in the conscious patient. Ann Thorac Surg (2007) 1.63
Regional wall motion abnormalities and scarring in severe functional ischemic mitral regurgitation: A pilot cardiovascular magnetic resonance imaging study. J Thorac Cardiovasc Surg (2009) 1.63
Pericardial delayed hyperenhancement with CMR imaging in patients with constrictive pericarditis undergoing surgical pericardiectomy: a case series with histopathological correlation. JACC Cardiovasc Imaging (2011) 1.63
Clinical experience with the TandemHeart percutaneous ventricular assist device. Tex Heart Inst J (2006) 1.62
Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction. Circulation (2009) 1.61
Temporal trends in utilization of cardiac computed tomography. J Cardiovasc Comput Tomogr (2008) 1.61
End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices. J Heart Lung Transplant (2007) 1.60
Total circulatory support with an LVAD in an adolescent with a previous Fontan procedure. Tex Heart Inst J (2005) 1.58
Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum (2002) 1.56
Bacterial mediastinitis after heart transplantation. J Heart Lung Transplant (1992) 1.56
Initial experience with the AbioCor implantable replacement heart system. J Thorac Cardiovasc Surg (2004) 1.54
Clinical experience with sternotomy versus subcostal approach for exchange of the HeartMate XVE to the HeartMate II ventricular assist device. Ann Thorac Surg (2008) 1.54
Flail tricuspid leaflet after multiple biopsies following orthotopic heart transplantation: echocardiographic and hemodynamic correlation. J Heart Lung Transplant (1994) 1.52
Myocardial thievery: the coronary-subclavian steal syndrome. Ann Thorac Surg (2006) 1.52
Evaluation of myocardial function in patients with end-stage heart failure during support with the Jarvik 2000 left ventricular assist device. J Heart Lung Transplant (2005) 1.51
Effect of dual-source cardiac computed tomography on patient radiation dose in a clinical setting: comparison to single-source imaging. J Cardiovasc Comput Tomogr (2008) 1.51
Advanced heart failure: feasibility study of long-term continuous axial flow pump support. Eur Heart J (2005) 1.49
Direct thrombolytic therapy for intraventricular thrombosis in patients with the Jarvik 2000 left ventricular assist device. J Heart Lung Transplant (2005) 1.48
Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. J Heart Lung Transplant (2005) 1.47
Atrial fibrillation after cardiac transplantation: experience in 498 consecutive cases. Ann Thorac Surg (2008) 1.46
Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study. JACC Cardiovasc Imaging (2009) 1.46
Patent foramen ovale: a cause of hypoxemia in patients on left ventricular support. Ann Thorac Surg (1991) 1.45
Role of MRI in clinical cardiology. Lancet (2004) 1.44
Cardiac tumors. Clinical spectrum and prognosis of lesions other than classical benign myxoma in 20 patients. J Thorac Cardiovasc Surg (1984) 1.43
Effect of pump flow mode of novel left ventricular assist device upon end organ perfusion in dogs with doxorubicin induced heart failure. ASAIO J (2005) 1.41
First clinical use of the redesigned HeartMate II left ventricular assist system in the United States: a case report. Tex Heart Inst J (2004) 1.40
Usefulness of multislice spiral computed tomography coronary angiography in patients with acute chest pain in the emergency department. J Cardiovasc Comput Tomogr (2007) 1.40
Endomyocardial nodular calcification as a cause of heart failure. Cardiovasc Pathol (2010) 1.40
Thrombogenicity of mechanical aortic valves in an animal model: site specific testing is crucial. ASAIO J (2004) 1.39
Cardiac transplantation in Puerto Rican patients at the Texas Heart Institute. Bol Asoc Med P R (1991) 1.39
SCMR president's page. J Cardiovasc Magn Reson (2011) 1.39
Lung cancer after heart transplantation: a 17-year experience. Ann Thorac Surg (2005) 1.39
TandemHeart as a rescue therapy for patients with critical aortic valve stenosis. Ann Thorac Surg (2009) 1.39
Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant (2011) 1.38
The AbioCor implantable replacement heart. Ann Thorac Surg (2003) 1.38
Preclinical assessment of a trileaflet mechanical valve in the mitral position in a calf model. Ann Thorac Surg (2004) 1.38
A surgical case for hemolytic anemia after ascending and total arch replacement. Ann Thorac Cardiovasc Surg (2005) 1.38
Hemodynamic support with a percutaneous left ventricular assist device during stenting of an unprotected left main coronary artery. Tex Heart Inst J (2004) 1.38